Welcome to LookChem.com Sign In|Join Free

CAS

  • or
7-Bromo-2H-indazole, with the molecular formula C7H5BrN2, is an indazole derivative featuring a bromine atom attached to the 7th position of the indazole ring. This chemical compound is recognized for its potential biological activities and is widely utilized in pharmaceutical and research applications, particularly in the development of drug candidates. Its versatility makes it a valuable component in medicinal chemistry for the synthesis of novel molecules.

845751-59-9

Post Buying Request

845751-59-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

845751-59-9 Usage

Uses

Used in Pharmaceutical Research and Development:
7-Bromo-2H-indazole is used as a chemical intermediate for the synthesis of new drug candidates due to its unique structure and potential biological activities.
Used in Anticancer Research:
7-Bromo-2H-indazole is used as a potential anticancer agent, given its observed biological activities that may contribute to the inhibition of cancer cell growth and proliferation.
Used in Antimicrobial Research:
7-Bromo-2H-indazole is used as a potential antimicrobial agent, indicating its possible application in the development of new treatments for infectious diseases.
Used in Medicinal Chemistry Research:
7-Bromo-2H-indazole is used as a building block in the synthesis of novel molecules, facilitating the discovery of new compounds with therapeutic potential.

Check Digit Verification of cas no

The CAS Registry Mumber 845751-59-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,5,7,5 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 845751-59:
(8*8)+(7*4)+(6*5)+(5*7)+(4*5)+(3*1)+(2*5)+(1*9)=199
199 % 10 = 9
So 845751-59-9 is a valid CAS Registry Number.

845751-59-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 7-Bromo-1H-indazole

1.2 Other means of identification

Product number -
Other names 7-bromo-indan-1-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:845751-59-9 SDS

845751-59-9Relevant articles and documents

Design and Synthesis of a Novel Series of Bicyclic Heterocycles As Potent γ-Secretase Modulators

Bischoff, Francois,Berthelot, Didier,De Cleyn, Michel,MacDonald, Gregor,Minne, Garrett,Oehlrich, Daniel,Pieters, Serge,Surkyn, Michel,Trabanco, Andres A.,Tresadern, Gary,Van Brandt, Sven,Velter, Ingrid,Zaja, Mirko,Borghys, Herman,Masungi, Chantal,Mercken, Marc,Gijsen, Harrie J. M.

, p. 9089 - 9106,18 (2020/10/15)

The design and the synthesis of several chemical subclasses of imidazole containing γ-secretase modulators (GSMs) is described. Conformational restriction of pyridone 4 into bicyclic pyridone isosteres has led to compounds with high in vitro and in vivo p

GABANERGIC MODULATORS

-

, (2010/02/10)

This invention relates to the use of compounds of benzoindazole derivatives salts and solvates thereof for the preparation of a medicament for modulating alpha2 subtype GABA A receptors. The invention further relates to novel heterocyclic compounds and pharmaceutical compositions containing said compounds. In addition the invention relates to the use of compounds of formula (I) salts and solvates thereof for the preparation of a medicament for the treatment of depression, an anxiety disorder, a psychiatric disorder, a learning or cognitive disorder, a sleep disorder, a convulsive or seizure disorder or pain.

Indazole derivatives as CRF antagonists

-

Page/Page column 19, (2010/02/07)

This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: wherein R3 is optionally substituted aryl or heteroaryl, R1 and R2 are as defined in

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 845751-59-9